Optimizing care for patients with non-traumatic intracerebral hemorrhage
Official title: Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)
Run by University Hospital, Tours · NCT06802588 · Data updated 2026-11-12
This study is testing a new emergency care plan for patients with non-traumatic brain bleeding to see if it can improve their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 3 sites (Angers and 2 other locations) |
| Status | Recruiting |
| Started | May 1, 2022 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT06802588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are admitted urgently to the University Hospital of Tours with a confirmed diagnosis of ICH.
✕Probably not a fit
Patients who have opted out of data collection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the management of patients with non-traumatic intracerebral hemorrhage (ICH) at the University Hospital of Tours. It includes a retrospective analysis of patients admitted between 2018-2021 and a prospective evaluation of current management practices. The study focuses on implementing a standardized protocol for emergency care, including rapid imaging, antihypertensive treatment, and follow-up evaluations. The goal is to improve patient outcomes by analyzing and optimizing the acute management of ICH.
Why it matters
Potential benefit: If successful, this study could lead to improved survival rates and reduced disability for patients suffering from ICH.
How similar studies have gone: Preliminary data from other studies suggest that improved management protocols for ICH have led to better survival rates, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged over 18 years * emergency admission to the University Hospital of Tours * having an ICH on imaging performed upon admission (CT scan or MRI) at the University Hospital of Tours Exclusion criteria : \- Patient who has given their opposition to the collection of their data
Where it's running
-
University Hospital of Angers
Angers, France Recruiting -
University Hospital of Poitiers
Poitiers, France Recruiting -
University Hospital Center of Tours
Tours, France Recruiting
Study contacts
- Principal investigator: Marco PASI, MD, PHD — neurovascular unit, neurology department, CHRU Tours
- Study coordinator: Marco PASI, MD, PHD
- Email: M.PASI@chu-tours.fr
- Phone: +33 0247478024
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Chinese multicenter group studies spontaneous intracerebral hemorrhage in adults
This study tests how a large group of adults with spontaneous intracerebral hemorrhage (and a healthy control group) progress over time to understand outcomes and determinants of recovery.
-
Rapid Evacuation and Access of Cerebral Hemorrhage Registry: observing minimally invasive surgery outcomes
This registry collection tests how minimally invasive brain-bleed procedures work in real patients with acute spontaneous intracerebral hemorrhage.
-
Single triple-combination blood pressure pill after intracerebral hemorrhage
This trial tests whether a single pill combining amlodipine, valsartan, and hydrochlorothiazide helps adults who recently had an intracerebral hemorrhage control their blood pressure.
-
Vitamin D treatment after intracerebral hemorrhage
This will try giving higher-dose vitamin D to adults within 96 hours of an intracerebral hemorrhage to see if it helps clear the bleed faster and is safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.